Literature DB >> 35355849

Beyond medications: is pulmonary artery denervation the answer for pulmonary arterial hypertension?: PADN for PAH.

Fan Guo1, Zhi-Cheng Jing1.   

Abstract

Entities:  

Year:  2022        PMID： 35355849      PMCID： PMC8932649          DOI： 10.4244/AIJ-E-22-00001

Source DB:  PubMed          Journal:  AsiaIntervention        ISSN： 2426-3958


× No keyword cloud information.
  6 in total

1.  Fine structural study of the terminal effecror plexus, neuromuscular and intermuscular relationships in the pulmonary artery.

Authors:  M A Verity; J A Bevan
Journal:  J Anat       Date:  1968-06       Impact factor: 2.610

2.  Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature.

Authors:  C E Juratsch; J A Jengo; J Castagna; M M Laks
Journal:  Chest       Date:  1980-04       Impact factor: 9.410

3.  Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.

Authors:  Yuan Huang; Yi-Wei Liu; Hai-Zhou Pan; Xiao-Ling Zhang; Jun Li; Li Xiang; Jian Meng; Pei-He Wang; Jun Yang; Zhi-Cheng Jing; Hao Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

4.  Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).

Authors:  Shao-Liang Chen; Feng-Fu Zhang; Jing Xu; Du-Jiang Xie; Ling Zhou; Thach Nguyen; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

5.  Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.

Authors:  Shao-Liang Chen; Yao-Jun Zhang; Lin Zhou; Du-Jiang Xie; Feng-Fu Zhang; Hai-Bo Jia; Sally S Wong; Tak W Kwan
Journal:  EuroIntervention       Date:  2013-06-22       Impact factor: 6.534

6.  Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.

Authors:  Ling Zhou; Juan Zhang; Xiao-Min Jiang; Du-Jiang Xie; Jin-Song Wang; Li Li; Bin Li; Zhi-Mei Wang; Alexander M K Rothman; Allan Lawrie; Shao-Liang Chen
Journal:  JACC Cardiovasc Interv       Date:  2015-12-28       Impact factor: 11.195
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.